In-vitro Transcription Templates Market Size is valued at USD 277.5 Mn in 2023 and is predicted to reach USD 1,134.1 Mn by the year 2031 at a 19.5% CAGR during the forecast period for 2024-2031.
In-vitro transcription templates are essential for a range of research and diagnostic purposes. These include creating mRNA for gene expression analysis, producing probes for RNA hybridization assays, and generating templates for in-vitro translation. In-vitro transcription templates are precise DNA sequences that act as templates for the production of RNA molecules through an in-vitro transcription process, which occurs outside of live cells. These templates include a promoter region that is recognized by RNA polymerase, which starts the process of transcribing the DNA sequence downstream into a complementary RNA strand.
There is a high need for in-vitro transcription templates due to the growing interest in RNA-based research, which encompasses gene expression studies, transcriptomics, and RNA medications. Researchers are actively investigating the potential of RNA molecules in various applications, fueling the expansion of the market. Furthermore, the rise in genetic abnormalities and developments in gene-editing technologies drive the need for in-vitro transcription templates.
However, the market growth is hampered by the high-cost criteria for the safety and health of the in-vitro transcription templates market and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high in-vitro transcription templates because the exorbitant expense of R&D, which includes the creation of in-vitro transcription templates, can impede the expansion of the market. The process's high price tag makes it out of budget for smaller research labs and universities. In addition, Experts in molecular biology methods are needed in the area of in-vitro transcription. However, the lack of properly educated workers threatens the market's expansion and adoption. The market for in-vitro transcription templates has been affected in different ways by the COVID-19 epidemic. Even though the pandemic immediately hampered research and laboratory operations, it ultimately brought attention to the need for RNA-based research and therapies.
Competitive Landscape
Some Major Key Players In The In-vitro Transcription Templates Market:
- Thermo Fisher Scientific Inc.
- Promega Corporation
- Agilent Technologies, Inc.
- New England Biolabs
- Takara Bio Inc.
- LGC Limited
- Enzynomics Co. Ltd.
- Enzo Life Sciences, Inc.
- Danaher Corporation
- Genscript Biotech Corporation
- Eurofins Genomics LLC
- TriLink Biotechnologies LLC
- Bioline GMBH
- Lucigen Corporation
- Other Prominent Players
Market Segmentation:
The in-vitro transcription templates market is segmented based on disease type, treatment, and end-user. Based on disease type, the market comprises cancer, infectious disease, lifestyle disease, genetic disease, and others. By treatment, the market is segmented into vaccine, therapeutic. The research stage segment includes exploratory and clinical. By end-user, the market is segmented into pharmaceutical & biotechnology companies, CROs & CMOs, academics & research, and others.
Based On The Treatment, The Therapeutic Segment Is Accounted As A Major Contributor To The In-Vitro Transcription Templates Market.
The therapeutic in-vitro transcription templates market will hold a major global market share in 2022. The use of activity as a therapeutic tool is a function-based approach that considers the patient's current and future functional abilities through environment-specific activities and task-grading. A solid therapeutic connection allows the client to take an active role in their recovery, improving results. Although interest in gene therapy and RNA-based treatments continues to grow, there will be a greater need for therapeutic in-vitro transcription templates.
Pharmaceutical & Biotechnology Companies' Segment To Witness Growth At A Rapid Rate.
The pharmaceutical & biotechnology companies make up the bulk of acrylic acid ester usage because the pharmaceutical and healthcare organizations work on topics such as RNA engineering and modification, therapeutic applications, synthetic biology, high-throughput screening, improved transcription efficiency, and template design and engineering, especially in countries like the US, Germany, the UK, China, and India.
In The Region, The Asia Pacific In-Vitro Transcription Templates Market Holds A Significant Revenue Hare.
The Asia Pacific in-vitro transcription templates market is expected to register the maximum market revenue share in the near future. It can be attributed to substantial investments in molecular biology research, a robust research infrastructure, and the presence of important market participants.
Recent Developments:
- In Sept 2023, GenScript Biotech Corporation enhanced its IVT mRNA synthesis offerings by introducing personalized circular RNA (circRNA) and lipid nanoparticles (LNPs) formulation services. GenScript has promptly introduced new contract-manufactured reagent services as a demonstration of their dedication to offering state-of-the-art reagents that facilitate progress in areas such as vaccine development, protein replacement therapies, and gene and cell therapy.
- In September 2022, Thermo Fisher Scientific unveiled tailored Dynabeads technologies that facilitate the large-scale synthesis of mRNA. The Dynabeads™ Streptavidin for In Vitro Transcription & Dynabeads Carboxylic Acid for RNA Purification solutions facilitated the large-scale production and purification of mRNA for vaccine development and manufacturing at a Good Manufacturing Practice (GMP) level.
In-Vitro Transcription Templates Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 277.5 Mn |
|
Revenue Forecast In 2031 |
USD 1,134.1 Mn |
|
Growth Rate CAGR |
CAGR of 19.5% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Disease Type, Treatment, Research Stage And End-Use |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
|
Competitive Landscape |
Thermo Fisher Scientific Inc., Promega Corporation, Agilent Technologies, Inc., New England Biolabs, Takara Bio Inc., LGC Limited, Enzynomics Co. Ltd., Enzo Life Sciences, Inc., and Danaher Corporation, Genscript Biotech Corporation, Eurofins Genomics LLC, TriLink Biotechnologies LLC, Bioline GMBH, Lucigen Corporation |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
